Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
337.02
-6.32 (-1.84%)
Aug 20, 2026, 4:00 PM EDT - Market closed

Krystal Biotech Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
241.46204.8389.1610.93-139.98-69.57
Depreciation & Amortization
2.372.453.214.813.392.77
Loss (Gain) From Sale of Assets
----100--
Loss (Gain) From Sale of Investments
-5.26-6.45-7.78-7.280.1-
Stock-Based Compensation
54.6854.5149.1339.9333.2315.32
Other Operating Activities
-18.24-18.064.151.320.031.04
Change in Accounts Receivable
-27.35-22.12-62.71-42.04--
Change in Inventory
-6.97-6.29-11.91-4.48--
Change in Accounts Payable
-0.120.831.01-0.1-1.250.71
Change in Income Taxes
-12.74-12.39-1.62---
Change in Other Net Operating Assets
44.513.5560.768.093.911.79
Operating Cash Flow
272.34200.87123.42-88.8-100.57-47.94
Operating Cash Flow Growth
39.38%62.75%----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-14.56-11.95-4.24-11.8-52.98-68.34
Sale of Property, Plant & Equipment
-0.44-100--
Investment in Securities
-203.73-46.9-159.2-5.56-61.1-158.43
Investing Cash Flow
-218.29-58.42-163.4482.64-114.08-226.77

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
41.0722.6632.4203.536355.65
Repurchase of Common Stock
-17.1-13.96-5.39-0.75-0.65-
Other Financing Activities
------7.96
Financing Cash Flow
23.978.7127.01202.7535.35347.69

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-4.110.29-0.46-0.16-0.04-
Net Cash Flow
73.91151.44-13.46196.43-179.3572.98

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
257.78188.91119.18-100.6-153.55-116.27
Free Cash Flow Growth
39.01%58.51%----
Free Cash Flow Margin
58.52%48.55%41.02%-198.43%--
Free Cash Flow Per Share
8.506.314.01-3.63-6.02-5.24
Levered Free Cash Flow
151.7493.9392.99-74.54-90.02-85.35
Unlevered Free Cash Flow
151.7493.9392.99-74.54-90.02-84.41

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
15.6415.675.67---
Change in Working Capital
-2.67-36.42-14.46-38.522.662.51
SEC Filings: 10-K · 10-Q